Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | MLYCD | O95822 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2310527 | 0.89 | ALDH1A1 (0.42) | CA12CA1CA9ALDH1A1ALDH2 | |
| SCHEMBL176291 | 0.84 | — | — | |
| SCHEMBL14197152 | 0.82 | MLYCD (0.38) | CA12CA1CA2CA9MAPT | |
| SCHEMBL20472201 | 0.80 | CA12 (0.46) | TP53CA12CA1CA2CA9 | |
| SCHEMBL4324459 | 0.78 | CA12 (0.32) | CA12CA1CA2CA9MAPT | |
| SCHEMBL4485645 | 0.78 | CA12 (0.32) | CA12CA1CA2CA9MAPT | |
| SCHEMBL26535305 | 0.78 | CHRNB2 (0.43) | TP53MAPTCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL2308882 | 0.76 | L3MBTL1 (0.49) | ALDH1A1 | |
| SCHEMBL13197599 | 0.76 | ALDH1A1 (0.34) | CA12CA1CA2CA9MAPT | |
| SCHEMBL811518 | 0.76 | CA12 (0.50) | CA12CA1CA2CA9ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025125392-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-06-19 | — | — | WO | claimed |
| US-20170362454-A1 | WATER BASED MAGNETIC INK CHARACTER RECOGNITION INK JET INK BASED ON DISPERSION OF FUNCTIONALIZED NANOPARTICULATE MAGNETIC FERRITE | NANUM NANOTECNOLOGIA S/A (BR) | 2017-12-21 | — | — | US | claimed |
| US-20160208120-A1 | WATER BASED MAGNETIC INK CHARACTER RECOGNITION INK JET INK BASED ON DISPERSION OF FUNCTIONALIZED NANOPARTICULATE MAGNETIC FERRITE | NANUM NANOTECNOLOGIA S/A (BR) | 2016-07-21 | — | — | US | claimed |
| EP-1758468-B1 | TASTE IMPROVING SUBSTANCES | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2011-03-02 | — | — | EP | claimed |
| US-4143159-A | SKIN-CARE AGENTS CONTAINING HYDROXYALKYL CARBOXAMIDES AND PROCESS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1979-03-06 | — | — | US | claimed |
| EP-4658246-A1 | COMPOSITIONS COMPRISING HYDROPHILIC ACTIVE INGREDIENTS IN OIL | Lubrizol Advanced Materials, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| US-20250360146-A1 | COMPOSITIONS FOR SEBUM CONTROL | DYSON OPERATIONS PTE LTD (SG) | 2025-11-27 | — | — | US | disclosed |
| US-20250352445-A1 | COMPOSITIONS FOR SEBUM CONTROL | DYSON OPERATIONS PTE LTD (SG) | 2025-11-20 | — | — | US | disclosed |
| WO-2025125392-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025083495-A1 | COMPOSITIONS FOR SEBUM CONTROL | Dyson Operations PTE. LTD. (SG) | 2025-04-24 | — | — | WO | disclosed |
| WO-2025083496-A1 | COMPOSITIONS FOR SEBUM CONTROL | Dyson Operations PTE. LTD. (SG) | 2025-04-24 | — | — | WO | disclosed |
| US-20250107986-A1 | Organic Ricinoleate Salts As Deodorizing Agents | COLONIAL CHEMICAL, INC. | 2025-04-03 | — | — | US | disclosed |
| US-20170362454-A1 | WATER BASED MAGNETIC INK CHARACTER RECOGNITION INK JET INK BASED ON DISPERSION OF FUNCTIONALIZED NANOPARTICULATE MAGNETIC FERRITE | NANUM NANOTECNOLOGIA S/A (BR) | 2017-12-21 | — | — | US | disclosed |
| US-20160208120-A1 | WATER BASED MAGNETIC INK CHARACTER RECOGNITION INK JET INK BASED ON DISPERSION OF FUNCTIONALIZED NANOPARTICULATE MAGNETIC FERRITE | NANUM NANOTECNOLOGIA S/A (BR) | 2016-07-21 | — | — | US | disclosed |
| US-5916474-A | BLOCK POLYMER OF CAPROLACTAM AND ALKYLENE OXIDE WITH ALKYLENE OXIDE UNIT CAPPED WITH ALKANOL FATTY AMINE OR AMIDE | TAKEMOTO YUSHI KABUSHIKI KAISHA (JP) | 1999-06-29 | — | — | US | disclosed |
| US-5628833-A | Two-step cleaning or dewatering with siloxane azeotropes | DOW CORNING CORPORATION (US) | 1997-05-13 | — | — | US | disclosed |
| US-5417895-A | Bonding agents for HTPB-type solid propellants | AEROJET GENERAL CORPORATION (US) | 1995-05-23 | — | — | US | disclosed |
| US-5009880-A | Mixture of an anionic and cationic polymer for shampoos, skin lotions, nail strengtheners and hair dyeing; improved fixing and anchoring; smoothness; gloss | L'OREAL (FR) | 1991-04-23 | — | — | US | disclosed |
| US-4719099-A | ANIONIC AND CATIONIC | L'OREAL (FR) | 1988-01-12 | — | — | US | disclosed |
| US-4240450-A | HAIR CONDITIONER OF ANIONIC POLYMERS AND CATIONIC POLYMERS | L'OREAL (FR) | 1980-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352445-A1 | COMPOSITIONS FOR SEBUM CONTROL | CUTA, CYP46A1, CERT1 | TP53 1598/4885CA12 2296/4885CA1 1905/4885 |
| US-20250107986-A1 | Organic Ricinoleate Salts As Deodorizing Agents | DPM1, TYR, DDT | TP53 2034/4885CA12 3762/4885CA1 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.